Alcon (ALC) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • 14 hours ago

3 Medical Instrument Stocks Betting on GenAI to Ease Industry Hurdles

GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech.

Zacks Investment Research • Jul 17, 2026

Why Alcon (ALC) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jul 14, 2026

Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H

ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound.

Zacks Investment Research • Jul 14, 2026

DELL & 3 More Stocks With Strong Interest Coverage to Buy Now

DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs.

Zacks Investment Research • Jul 13, 2026

Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology

ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment.

Zacks Investment Research • Jul 13, 2026

RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook

RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses.

MarketBeat • Jul 11, 2026

Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know

The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Zacks Investment Research • Jul 9, 2026

ALC vs. IDXX: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?

Zacks Investment Research • Jul 7, 2026

Here's Why Alcon (ALC) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Jul 6, 2026